MedTrace Logo

Personal Therapy Comfort Settings Pilot Clinical Study

NCT05376137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2023-11-18

No results posted yet for this study

Summary

350 participants will be enrolled in this study. The target population are patients newly diagnosed with OSA and starting CPAP treatment.

User accessible customizable comfort settings (Response setting, expiratory pressure relief (EPR) on/off and EPR level, and Ramp) will be set to either default (control group), or personalized for that participant (active treatment group).

Usage will be recorded for the first 1 month of CPAP treatment, to determine if customizing comfort settings can improve CPAP compliance

Conditions

Interventions

DEVICE

continuous positive airway pressure (CPAP)

CPAP comfort settings will be modified in the active group to be personalized to each participant

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Jeff Armitstead, PhD · ResMed

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-15
Primary Completion
2023-06-30
Completion
2023-09-13

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05376137 on ClinicalTrials.gov